Array BioPharma

Overview

• Industrypharmaceutical industry¹
• HeadquartersBoulder¹
• Websitewww.arraybiopharma.com

See how the biggest companies compare on our leaderboards

Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is currently a subsidiary of Pfizer after being acquired for $11 billion in 2019.²

Corporate structure

Array BioPharma is part of a group headed by Pfizer. 367 entities, 64 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

Timeline

1. 1998Founded Founded¹

Calendar

Drug trials and FDA: recently

1. Feb 24, 2026FDA approved a new use FDA approved an efficacy supplement for Braftovi (encorafenib), a new use or patient group (NDA 210496, supplement 21).³
2. Mar 12, 2025FDA approved a new use FDA approved an efficacy supplement for Braftovi (encorafenib), a new use or patient group (NDA 210496, supplement 18).⁴
3. Mar 12, 2025FDA approved a new use FDA approved an efficacy supplement for Mektovi (binimetinib), a new use or patient group (NDA 210498, supplement 11).⁵
4. Dec 20, 2024FDA approved a new use FDA approved an efficacy supplement for Braftovi (encorafenib), a new use or patient group (NDA 210496, supplement 17).⁶
5. Sep 12, 2024FDA approved a new use FDA approved an efficacy supplement for Braftovi (encorafenib), a new use or patient group (NDA 210496, supplement 16).⁷

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Links

• Websitewww.arraybiopharma.com¹
• WikipediaArray BioPharma
• WikidataQ22090101